Modified USA Narrow 250mm — Robotic Colorectal Surgery

Modified USA Narrow 250mm — Robotic Colorectal Surgery

The 250mm Modified USA Narrow dressing forceps serves robotic colorectal surgery — increasingly used for rectal cancer in particular, where the robotic platform’s technical advantages in the deep pelvis are most pronounced. Robotic low anterior resection has produced lower conversion rates and equivalent oncological outcomes to laparoscopic low anterior resection in the published RCT data.

The robotic-rectal-cancer surgery advantage

Total mesorectal excision (TME) for rectal cancer demands precise dissection along the embryologic mesorectal envelope — a technically demanding step in the deep pelvis. Robotic technology provides improved three-dimensional visualisation and dexterity in this confined space, supporting better TME dissection. The 25cm Modified USA Narrow forceps populates the open-conversion tray for these procedures.

The ROLARR trial outcomes

The 2017 ROLARR trial showed equivalent conversion rates between robotic and laparoscopic rectal cancer surgery, supporting the technical interchangeability of these approaches at experienced centres. Both pathways require an open-conversion tray for the small proportion of cases needing conversion.